Our findings showed a significant upregulation of TLR2 and TLR4 expression levels in the cisplatin-treated group, which revealed the role of TLR2 and TLR4 in renal injury as it induces pathologic characteristics in AKI, including cisplatin-induced ones [42,43]. Here, TLR4 is linked to acute kidney injury.